Study Site — Chapel Hill, North Carolina

Study Site is a clinical research site located in Chapel Hill, North Carolina, United States 27517.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Study Site has participated in 7 clinical trials.

Therapeutic areas: Schizophrenia, Food Allergy, Sickle Cell Disease.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc., Alladapt Immunotherapeutics, Inc., Icagen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chapel Hill

Browse all research sites in North Carolina · View every site in Chapel Hill

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site?

Study Site has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site conducted?

Study Site has 7 clinical trials on record. Their work covers Schizophrenia, Food Allergy, Sickle Cell Disease.

Is Study Site accredited by Crixeo Clinical Trials?

Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.